Page 55 - 《中国药房》2024年15期
P. 55

基于Notch信号通路探讨牡荆素对哮喘模型小鼠的改善作用
                                                                                                      Δ


                          2 #
                                   2
                 1*
          费园园 ,葛明坤 ,卞庆平(1.东南大学附属中大医院江北院区感染科,南京 210044;2.东南大学附属中大
          医院江北院区呼吸科,南京 210044)
          中图分类号  R965      文献标志码  A      文章编号  1001-0408(2024)15-1849-06
          DOI  10.6039/j.issn.1001-0408.2024.15.09

          摘  要  目的  基于Notch信号通路探究牡荆素对哮喘模型小鼠的改善作用及机制。方法  采用卵清蛋白与氢氧化铝混悬液腹腔
          注射和卵清蛋白雾化激发的方法构建哮喘小鼠模型。将哮喘小鼠随机分为模型组、牡荆素组(40 mg/kg)、Notch激活剂组(1 mg/kg
          Jagged1)、牡荆素+Notch激活剂组(40 mg/kg牡荆素+1 mg/kg Jagged1),每组12只;另取12只小鼠设为对照组。各组小鼠灌胃/腹
          腔注射相应药物或生理盐水,每天1次,连续14 d。末次给药后,检测小鼠静息每分钟通气量(VE)、呼气峰流速(PEF),观察肺组
          织病理形态并检测纤维化变性情况,测定外周血中辅助性T细胞17(Th17)、调节性T细胞(Treg)比例并计算Th17/Treg值,测定血
          清中白细胞介素18(IL-18)、IL-6、IL-17、IL-10水平,检测肺组织中Notch1、Delta样配体4(DLL4)、发状分裂相关增强子1(Hes1)蛋
          白表达。结果  与对照组比较,模型组小鼠肺组织发生严重病理损伤及炎症细胞浸润;VE、PEF、外周血中Treg细胞比例、血清中
          IL-10水平均显著降低(P<0.05);肺组织中胶原容积分数(CVF),外周血中Th17细胞比例、Th17/Treg值,血清中IL-18、IL-6、IL-17
          水平,肺组织中Notch1、DLL4、Hes1蛋白表达水平均显著升高(P<0.05)。与模型组比较,牡荆素组小鼠肺组织病理损伤明显改
          善,上述指标变化趋势被显著逆转(P<0.05),且Notch激活剂Jagged1可显著逆转牡荆素对哮喘小鼠的上述药理功效(P<0.05)。
          结论  牡荆素可通过抑制Notch信号通路,改善哮喘小鼠肺功能、Th17/Treg免疫失衡及炎症反应,减轻肺组织病理损伤及纤维化。
          关键词  牡荆素;Notch信号通路;哮喘;肺纤维化;Th17/Treg免疫失衡;炎症


          Improvement effects of vitexin on asthmatic model mice based on Notch signaling pathway
                                    2
                      1
          FEI Yuanyuan ,GE Mingkun ,BIAN Qingping(1.  Dept.  of  Infectious  Diseases,  Jiangbei  Campus,  Zhongda
                                                    2
          Hospital,  Southeast  University,  Nanjing  210044,  China;2.  Dept.  of  Respiratory  Medicine,  Jiangbei  Campus,
          Zhongda Hospital, Southeast University, Nanjing 210044, China)
          ABSTRACT   OBJECTIVE  To  explore  the  improvement  effect  and  mechanism  of  vitexin  on  asthmatic  model  mice  based  on
          Notch  signaling  pathway.  METHODS  Asthma  model  of  mice  was  established  by  intraperitoneal  injection  of  ovalbumin  and
          aluminum hydroxide suspension and nebulization stimulation of ovalbumin, and randomly divided into model group, vitexin group
         (40 mg/kg), Notch activator group (1 mg/kg Jagged1), vitexin+Notch activator group (40 mg/kg vitexin+1 mg/kg Jagged1), with
          12 mice in each group. Another 12 mice were selected as the control group. Each group received intragastric/intraperitoneal injection
          of  relevant  medicine  or  normal  saline,  once  a  day,  for  consecutive  14  days. After  the  last  medication,  minute  ventilation  at  rest
         (VE) and peak expiratory flow (PEF) were detected in mice; the pathological morphology of lung tissue and fibrosis degeneration
          were  observed  and  determined.  The  proportion  of  T  helper  cell  17 (Th17)  and  T  regulatory  cell (Treg)  in  peripheral  blood  were
          detected,  and  the  Th17/Treg  ratio  was  calculated.  The  levels  of  serum  inflammatory  factors  interleukin (IL)-18,  IL-6,  IL-17  and
          IL-10 were determined, and the expressions of Notch1, Delta-like ligand 4 (DLL4), hairy and enhancer of split 1 (Hes1) in lung
          tissue  were  detected.  RESULTS  Compared  with  the  control  group,  serious  pathological  injury  and  inflammatory  cell  infiltration
          occurred in the lung tissue of mice in the model group, while VE, PEF, the proportion of Treg cells in peripheral blood and serum
          level  of  IL-10  were  significantly  reduced (P<0.05);  collagen  volume  fraction (CVF)  in  lung  tissue,  Th17  cells  proportion  and
          Th17/Treg  ratio  in  peripheral  blood,  serum  levels  of  IL-18,  IL-6  and  IL-17,  and  the  protein  expressions  of  Notch1,  DLL4  and
          Hes1 in lung tissue were significantly increased (P<0.05). Compared with the model group, the pathological injury of lung tissue
                                                             in  vitexin  group  was  significantly  improved  compared  with
             Δ 基金项目 江苏省卫生健康委科研项目(No.H2022039)                model  group,  and  the  changing  trend  of  the  above  indexes
             *第一作者 医师。研究方向:哮喘等感染性疾病诊治。E-mail:
                                                             was  reversed  (P<0.05);  Notch  activator  Jagged1  could
          feiyuanyuan5286@163.com
                                                             significantly  reverse  the  pharmacological  effects  of  vitexin  on
             #  通信作者 主治医师。研究方向:肺部感染性疾病诊治。
          E-mail:114647748@qq.com                            asthmatic  mice  (P<0.05).  CONCLUSIONS  Vitexin  can


          中国药房  2024年第35卷第15期                                              China Pharmacy  2024 Vol. 35  No. 15    · 1849 ·
   50   51   52   53   54   55   56   57   58   59   60